A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
Recruiting now
Conditions studied: Psoriasis
In brief
The purpose of this study is to assess the real-world effectiveness of deucravacitinib treatment in adults diagnosed with moderate-to-severe plaque psoriasis
Key facts
- Study ID
- NCT06701513
- Run by
- Bristol-Myers Squibb
- People needed
- 350
- Starts
- 2025-01-29
- Expected to finish
- 2028-04-30
- Last updated by the study team
- 2026-05-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥18 years of age
- Physician-reported diagnosis of moderate to severe plaque psoriasis
- Be newly initiating deucravacitinib
- Do not object to participate
You may not qualify if…
- Currently participating in or planning to participate in an interventional clinical trial
- Previous treatment experience with deucravacitinib, including patients who received deucravacitinib as part of a blinded, randomized trial
Where it is running
- Hopitaux de Brabois — Vandœuvre-lès-Nancy, France (enrolling)
- Cabinet Médical Elisabeth Lion — Angers, France (enrolling)
- Ch Victor Dupouy — Argenteuil, France (enrolling)
- Médipôle Hôpital Mutualiste — Villeurbanne, France (enrolling)
- Médipôle Hôpital Mutualiste — Villeurbanne, France (enrolling)
- Cabinet Medical — La Chaux-de-Fonds, Switzerland (enrolling)
- Cabinet Medical — La Chaux-de-Fonds, Switzerland (enrolling)
- Cabinet Medical — La Chaux-de-Fonds, Switzerland (enrolling)
- Cabinet Medical — La Chaux-de-Fonds, Switzerland (enrolling)
- Cabinet Medical — La Chaux-de-Fonds, Switzerland (enrolling)
- Cabinet Medical — La Chaux-de-Fonds, Switzerland (enrolling)
- Cabinet Medical — La Chaux-de-Fonds, Switzerland (enrolling)
- CH ARRAS — Arras, France (enrolling)
- Cabinet Dermatologie — Bordeaux, France (enrolling)
- Cabinet Dermatologie — Bordeaux, France (enrolling)
- Centre Hospitalier William Morey - Hématologie — Chalon-sur-Saône, France (enrolling)
- CHU Dijon — Dijon, France (enrolling)
- CHU Grenoble Alps, Service de Dermatologie — La Tronche, France (enrolling)
- CH Emile Roux — Le Puy-en-Velay, France (enrolling)
- Centre Hospitalier Lens — Lens, France (enrolling)
- Centre de santé Filieris — Marcq-en-Barœul, France (enrolling)
- Hopital Saint Eloi — Montpellier, France (enrolling)
- Tagast 41 — Nice, France (enrolling)
- Ch Georges Renon — Niort, France (enrolling)
- Ch Georges Renon — Niort, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.